Appraisal of Prognostic Interaction between Sidedness and Mucinous Histology in Colon Cancer: A Population-Based Study Using Inverse Probability Propensity Score Weighting

被引:4
作者
Wang, Zi-Xian [1 ]
Yang, Lu-Ping [1 ,2 ]
Wu, Hao-Xiang [1 ,2 ]
Yang, Dong-Dong [1 ]
Ding, Pei-Rong [3 ]
Xie, Dan [4 ]
Chen, Gong [3 ]
Li, Yu-Hong [1 ]
Wang, Feng [1 ]
Xu, Rui-Hua [1 ]
机构
[1] Sun Yat Sen Univ, Dept Med Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, 651 Dong Feng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Fac Med Sci, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Dept Colorectal Surg, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Dept Pathol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China
来源
JOURNAL OF CANCER | 2019年 / 10卷 / 02期
关键词
colon cancer; tumor side; mucinous histology; survival; surveillance; epidemiology; end results; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; PROXIMAL COLON; BRAF MUTATION; STAGE-II; SURVIVAL; ADENOCARCINOMA; PREDICTS; CHEMOTHERAPY; SUBTYPES;
D O I
10.7150/jca.28014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Colon cancer with different sidedness (right vs. left) and histology (mucinous vs. non-mucinous) may represent different disease entities. We investigated whether the prognostic values of sidedness and histology differed according to each other. Materials and Methods: We analyzed 81342 patients with stage II-IV colon cancer from the Surveillance, Epidemiology, and End Results database between 2004 and 2012. Patients were divided into four subgroups on the basis of sidedness and histology: non-mucinous right-sided, non-mucinous left-sided, mucinous right-sided, and mucinous left-sided subgroups. Among each tumor stage, median overall survival (mOS) was compared between these subgroups after inverse probability propensity score weighting to handle confounding factors. Results: In the stage IV subgroup, the prognosis for non-mucinous left-sided tumors (weighted mOS, 24.5 months) was significantly better than that for non-mucinous right-sided tumors (weighted mOS, 16.5 months; P<0.001) and that for mucinous left-sided tumors (weighted mOS, 16.5 months; P<0.001), whereas the survival was similar between left-sided and right-sided tumors with the mucinous subtype (weighted mOS, 16.5 months for both; P=0.570; test for interaction between sidedness and histology, P-interaction<0.001), and between mucinous and non-mucinous tumors in the right-sided colon (weighted mOS, 16.5 months for both; P=0.207). Similar findings were detected in the stage III subgroup (P-interaction<0.001). In the stage II subgroup, the survival was comparable among the four sidedness-histology subgroups (P=0.159 and P-interaction=0.466). Conclusions: In stage III/IV colon cancer, the prognostic value of sidedness differed according to histology, and vice versa. By contrast, neither should be considered in risk stratification for stage II colon cancer.
引用
收藏
页码:388 / 396
页数:9
相关论文
共 40 条
[31]   Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution-A Simulation Study [J].
Stuermer, Til ;
Rothman, Kenneth J. ;
Avorn, Jerry ;
Glynn, Robert J. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 172 (07) :843-854
[32]   BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer [J].
Tanaka, H ;
Deng, GR ;
Matsuzaki, K ;
Kakar, S ;
Kim, GE ;
Miura, S ;
Sleisenger, MH ;
Kim, YS .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) :2765-2771
[33]   Global Cancer Statistics, 2012 [J].
Torre, Lindsey A. ;
Bray, Freddie ;
Siegel, Rebecca L. ;
Ferlay, Jacques ;
Lortet-Tieulent, Joannie ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2015, 65 (02) :87-108
[34]   Impact of BRAF Mutation and Microsatellite Instability on the Pattern of Metastatic Spread and Prognosis in Metastatic Colorectal Cancer [J].
Tran, Ben ;
Kopetz, Scott ;
Tie, Jeanne ;
Gibbs, Peter ;
Jiang, Zhi-Qin ;
Lieu, Christopher H. ;
Agarwal, Atin ;
Maru, Dipen M. ;
Sieber, Oliver ;
Desai, Jayesh .
CANCER, 2011, 117 (20) :4623-4632
[35]   Impact of primary (1°) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance). [J].
Venook, Alan P. ;
Niedzwiecki, Donna ;
Innocenti, Federico ;
Fruth, Briant ;
Greene, Claire ;
O'Neil, Bert H. ;
Shaw, James Edward ;
Atkins, James Norman ;
Horvath, Laura E. ;
Polite, Blase N. ;
Meyerhardt, Jeffrey A. ;
O'Reilly, Eileen Mary ;
Goldberg, Richard M. ;
Hochster, Howard S. ;
Blanke, Charles David ;
Schilsky, Richard L. ;
Mayer, Robert J. ;
Bertagnolli, Monica M. ;
Lenz, Heinz-Josef .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[36]   Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis [J].
Verhulst, J. ;
Ferdinande, L. ;
Demetter, P. ;
Ceelen, W. .
JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (05) :381-388
[37]   Optimal Caliper Width for Propensity Score Matching of Three Treatment Groups: A Monte Carlo Study [J].
Wang, Yongji ;
Cai, Hongwei ;
Li, Chanjuan ;
Jiang, Zhiwei ;
Wang, Ling ;
Song, Jiugang ;
Xia, Jielai .
PLOS ONE, 2013, 8 (12)
[38]   Better survival in right-sided versus left-sided stage I - III colon cancer patients [J].
Warschkow, Rene ;
Sulz, Michael C. ;
Marti, Lukas ;
Tarantino, Ignazio ;
Schmied, Bruno M. ;
Cerny, Thomas ;
Gueller, Ulrich .
BMC CANCER, 2016, 16
[39]   Predictive value of mucinous histology in colon cancer: a population-based, propensity score matched analysis [J].
Warschkow, Rene ;
Tarantino, Ignazio ;
Huttner, Felix J. ;
Schmied, Bruno M. ;
Guller, Ulrich ;
Diener, Markus K. ;
Ulrich, Alexis .
BRITISH JOURNAL OF CANCER, 2016, 114 (09) :1027-1032
[40]   Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare Data [J].
Weiss, Jennifer M. ;
Pfau, Patrick R. ;
O'Connor, Erin S. ;
King, Jonathan ;
LoConte, Noelle ;
Kennedy, Gregory ;
Smith, Maureen A. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) :4401-4409